Showing results (301-310 of 335) with videos related to

Sort By:
Pageof 34
Nuklearmedizin. Nuclear Medicine|May 21, 2026
Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0Henryk Barthel, Matthias Brendel, Nathalie Albert, et al.
EMBO Molecular Medicine|May 25, 2019
Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolismJulia K Götzl, Matthias Brendel, Georg Werner, et al.
Frontiers in Aging Neuroscience|February 19, 2021
Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's DiseaseAnnika Kreuzer, Julia Sauerbeck, Maximilian Scheifele, et al.
Theranostics|December 8, 2025
Translational molecular imaging and drug development in multiple sclerosisDaniel Tay, Hazem Ahmed, Alyaa Dawoud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging IndicesPing Wu, Yu Zhao, Jianjun Wu, et al.
Brain Sciences|February 25, 2022
Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal SyndromeSebastian Schuster, Leonie Beyer, Carla Palleis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2024
Visual reading for [18F]Florzolotau Tau PET scans in progressive supranuclear palsyFeng-Tao Liu, Jia-Ying Lu, Xin-Yi Li, et al.
Nuklearmedizin. Nuclear Medicine|June 2, 2026
German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025)Ralph Buchert, Philipp T Meyer, Nathalie L Albert, et al.
NPJ Parkinson'S Disease|July 1, 2026
Multimodal neuroimaging elucidates the posterior-to-anterior gradient of nigrostriatal degeneration in Parkinson's diseaseHuamei Lin, Ying Zhang, Yixin Zhao, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 25, 2024
Aβ status assessment in a hypothetical scenario prior to treatment with disease-modifying therapies: Evidence from 10-year real-world experience at university memory clinicsMatthias Brendel, Tandis Parvizi, Johannes Gnörich, et al.
Pageof 34